BioCentury | Dec 15, 2008
Finance

Ebb & Flow

...said it would require the company to add boxed warnings to oral sodium phosphate products OsmoPrep...
BioCentury | Dec 15, 2008
Clinical News

Visicol regulatory update

...said in an alert that it would require Salix to add boxed warnings to its OsmoPrep...
...2006, the agency has received 20 reports of acute kidney injury associated with use of OsmoPrep...
...a colonoscopy and other medical procedures. Salix Pharmaceuticals Ltd. (NASDAQ:SLXP), Morrisville, N.C. Product: Visicol ; OsmoPrep...
BioCentury | Dec 12, 2008
Company News

Salix's OsmoPrep, Visicol to get boxed warnings

...said it would require the company to add boxed warnings to oral sodium phosphate products OsmoPrep...
...2006, the agency has received 20 reports of acute kidney injury associated with use of OsmoPrep...
BioCentury | Oct 8, 2007
Company News

Mayoly-Spindler S.A.S., Salix sales and marketing update

...SLXP granted Mayoly-Spindler exclusive rights to market OsmoPrep in France to cleanse the bowl. SLXP is...
...marketing approval in 1H09. The second-generation sodium phosphate purgative is marketed in the U.K. as Diacol...
BioCentury | Apr 23, 2007
Company News

Dr. Falk Pharma, Salix sales and marketing update

...SLXP granted Falk exclusive rights to market Diacol sodium phosphate 1,500 mg tablets in certain countires...
...and Italy, where Falk has a non-exclusive option to market the second-generation sodium phosphate purgative. Diacol...
...$1.5 million has already been paid, plus royalties. Diacol is marketed in the U.S. as OsmoPrep...
BioCentury | Dec 18, 2006
Clinical News

Diacol regulatory update

...The U.K.'s MHRA granted marketing approval for 1,500 mg tablets of Diacol to cleanse the colon...
...as a preparation for colonoscopy. The second-generation sodium phosphate purgative is marketed under the name OsmoPrep...
...a first-generation purgative, for the same indication. Salix Pharmaceuticals Ltd. (SLXP), Morrisville, N.C. Product: Diacol (OsmoPrep-U.S...
BioCentury | May 29, 2006
Clinical News

OsmoPrep: Post-marketing study updated data

...Pooled data from Phase II and Phase III trials comparing Osmoprep to Visicol showed that the...
...ACC) responders was significantly higher for both the 40 tablet (96%) and 32 tablet (94%) Osmoprep...
...Disease Week meetings in Los Angeles. Salix Pharmaceuticals Ltd. (SLXP), Morrisville, N.C. Product: OsmoPrep ( INKP-102...
BioCentury | Apr 24, 2006
Clinical News

OsmoPrep gastrointestinal data

...patients completing a scheduled colonoscopy showed that a significantly greater percentage of patients who used OsmoPrep...
...'excellent' compared to those who used the HalfLytely bowel preparation kit (p<0.0001). Patients received 32 OsmoPrep...
...FDA approved the product last month. Salix Pharmaceuticals Ltd. (SLXP), Morrisville, N.C. Product: OsmoPrep ( INKP-102...
BioCentury | Mar 20, 2006
Clinical News

OsmoPrep regulatory update

...FDA approved an NDA for OsmoPrep to cleanse the bowel prior to colonoscopy. The second-generation sodium...
...first-generation purgative, for the same indication. Salix Pharmaceuticals Ltd. (SLXP), Morrisville, N.C. Product: OsmoPrep ( INKP-102...
BioCentury | Mar 18, 2006
Company News

FDA approves Salix's OsmoPrep

...FDA approved OsmoPrep sodium phosphate tablets from Salix (SLXP) to cleanse the bowel prior to colonoscopy...
...to cleanse the bowel prior to colonoscopy. SLXP gained the second-generation sodium phosphate purgative (formerly INKP-102...
Items per page:
1 - 10 of 43